![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM158 |
Gene summary for TMEM158 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM158 | Gene ID | 25907 |
Gene name | transmembrane protein 158 | |
Gene Alias | BBP | |
Cytomap | 3p21.31 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | Q8WZ71 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
25907 | TMEM158 | C30 | Human | Oral cavity | OSCC | 3.88e-04 | 3.07e-01 | 0.3055 |
25907 | TMEM158 | C57 | Human | Oral cavity | OSCC | 4.12e-02 | 2.38e-01 | 0.1679 |
25907 | TMEM158 | SYSMH1 | Human | Oral cavity | OSCC | 3.80e-31 | 7.11e-01 | 0.1127 |
25907 | TMEM158 | SYSMH2 | Human | Oral cavity | OSCC | 3.99e-11 | 4.25e-01 | 0.2326 |
25907 | TMEM158 | SYSMH3 | Human | Oral cavity | OSCC | 3.31e-21 | 5.43e-01 | 0.2442 |
25907 | TMEM158 | SYSMH5 | Human | Oral cavity | OSCC | 9.33e-03 | 1.99e-01 | 0.0647 |
25907 | TMEM158 | ATC09 | Human | Thyroid | ATC | 1.97e-24 | 7.81e-01 | 0.2871 |
25907 | TMEM158 | ATC11 | Human | Thyroid | ATC | 2.02e-16 | 2.19e+00 | 0.3386 |
25907 | TMEM158 | ATC12 | Human | Thyroid | ATC | 2.62e-100 | 2.98e+00 | 0.34 |
25907 | TMEM158 | ATC1 | Human | Thyroid | ATC | 1.25e-25 | 9.23e-01 | 0.2878 |
25907 | TMEM158 | ATC2 | Human | Thyroid | ATC | 1.80e-12 | 7.99e-01 | 0.34 |
25907 | TMEM158 | ATC3 | Human | Thyroid | ATC | 2.69e-30 | 2.23e+00 | 0.338 |
25907 | TMEM158 | ATC4 | Human | Thyroid | ATC | 6.70e-115 | 3.37e+00 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Esophagus | ESCC | ![]() |
Skin | AK | ![]() |
Skin | SCCIS | ![]() |
Skin | cSCC | ![]() |
Thyroid | HT | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM158 | SNV | Missense_Mutation | c.757N>T | p.Pro253Ser | p.P253S | Q8WZ71 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.994) | TCGA-CK-6746-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM158 | SNV | Missense_Mutation | c.661N>A | p.Glu221Lys | p.E221K | Q8WZ71 | protein_coding | tolerated_low_confidence(0.08) | probably_damaging(0.979) | TCGA-86-8358-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
TMEM158 | SNV | Missense_Mutation | novel | c.662N>C | p.Glu221Ala | p.E221A | Q8WZ71 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.979) | TCGA-HU-A4GQ-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |